Page last updated: 2024-11-11

tocol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tocol: synthetic with antiproliferative and proapoptotic effects; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tocol : A chromanol with a chroman-6-ol skeleton that is substituted at position 2 by a saturated or triply-unsaturated hydrocarbon chain consisting of three isoprenoid units. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9865117
SCHEMBL ID74101
MeSH IDM0574137

Synonyms (22)

Synonym
2-methyl-2-(4,8,12-trimethyltridecyl)chroman-6-ol
SCHEMBL74101
tocol
2-methyl-2-phytyl-6-hydroxychroman
2-methyl-2-phytyl-6-chromanol
desmethyltocopherol
119-98-2
unii-s2xee7ob8x
6-hydroxy-2-methyl-2-phytylchroman
2-methyl-2-(4,8,12-trimethyltridecyl)-6-chromanol
s2xee7ob8x ,
2h-1-benzopyran-6-ol, 3,4-dihydro-2-methyl-2-(4,8,12-trimethyltridecyl)-
tocol [mi]
DFUSDJMZWQVQSF-UHFFFAOYSA-N
3,4-dihydro-2-methyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-ol
(+/-)-tocol
DTXSID10871602
2-methyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2h-1-benzopyran-6-ol
Q27288500
2-methyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-ol
STARBLD0003595
mfcd08703020
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's17 (80.95)24.3611
2020's4 (19.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 101.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index101.47 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index179.48 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (101.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.76%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (90.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]